News | Blood Testing | November 18, 2015

Konica Minolta Starting In Vitro Diagnostics Business in European, American Markets

Company’s SPFS Immunoassay System on reference exhibit at MEDICA 2015 in Germany

November 18, 2015 — Konica Minolta Inc. announced that it has developed the SPFS Immunoassay System, capable of highly sensitive measurements based on the fluorescent antibody technique. A prototype will be on reference exhibit at MEDICA 2015, the world’s largest international medical equipment fair in Dusseldorf, Germany, Nov. 16-19, 2015.

As a diagnostic method for myocardial infarction, malignancies and other pathologic conditions, the fluorescent antibody technique is used to detect disease-associated biomarkers (proteins) in the blood by means of the light generated with the use of a labeled antibody (an antibody coupled with a chemical substance known as a fluorescent marker). Recognizing that its technologies could be useful for increasing the sensitivity of the fluorescent antibody technique, Konica Minolta has been developing the SPFS Immunoassay System.

Specifically, the company’s nanotechnology and fine chemical technology that have emerged and evolved from the development of photographic films make chemical reactions highly controllable, and allow target antibodies to be detected with high sensitivity at the molecular level. In addition, the lens design know-how and light-guiding technology honed through the development of cameras are expected to be particularly useful in the detection of weak light and fluorescence, as well as other situations, thus improving the performance of such tests.

Among acute myocardial infarction patients who are admitted to hospital for emergency treatment for chest pain, those with non-ST elevation acute coronary syndromes are expected to enjoy shorter recovery times after treatment and lower mortality rates by starting early diagnosis and treatment with the use of highly sensitive testing. However, the conventional test with troponin (a biomarker (protein) in heart muscle), which is currently used for diagnosing myocardial infarction, requires about 6 hours for diagnosis, and is reported to have accuracy problems, causing various major issues in emergency medicine, including overcrowding.

Konica Minolta has developed the SPFS Immunoassay System, which comprises a compact unit for highly sensitive measurement of troponin with a diagnosis time of just 3 hours, and a set of heart disease-related reagents, including troponin. The system will be able to dramatically increase the efficiency of diagnostic and other clinical activities, and lessen overcrowding in emergency care settings, thus helping to reduce patient mortality rates and facilitate early recovery and discharge.

Furthermore, the SPFS Immunoassay System can accurately detect disease-specific biomarkers (proteins found specifically in target diseases) to provide a highly reliable immunoassay system not only for heart diseases such as myocardial infarction, but also for malignancies and other diseases, thus improving medical care.

Konica Minolta is planning to launch the SPFS Immunoassay System incorporating markers related to heart diseases primarily in Europe in 2017, and then sell it in both the European and American markets.
The company is also planning to create a more efficient immunoassay system with a greater number of test parameters, and to fully enter the in vitro diagnostics market with the high-sensitivity immunoassay system.

For more information: www.konicaminolta.com

Related Content

NIAID Scientists Illuminate Mechanism of Increased Cardiovascular Risks With HIV
News | Cardiac Diagnostics| September 14, 2017
September 14, 2017 — Scientists at the National Institutes of Health have expanded the understanding of how chronic i
Marijuana Associated With Three-Fold Risk of Death From Hypertension
News | Hypertension| September 14, 2017
Marijuana use is associated with a three-fold risk of death from hypertension, according to research published recently...
News | Cardiac Diagnostics| September 12, 2017
Contracting shingles, a reactivation of the chickenpox virus, increases a person’s risk of stroke and heart attack,...
Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study in Denmark

Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study. Photo credit: Lisbeth Hasager Justesen, Viborg Hospital.

News | Cardiac Diagnostics| September 12, 2017
September 12, 2017 — A new screening program for vascular disease saves one life for every 169 men assessed, accordin
PURE study may cause revision of fat intake guidelines for cardiology.
Feature | ESC| September 07, 2017
September 7, 2017 — Researchers at the European Society of Cardiology (ESC) Congress called for a reconsideration of
Florida Medical Center First in State to Offer High Sensitive STAT Blood Test
News | Blood Testing| September 07, 2017
In July, The Heart Institute at Florida Medical Center became the first hospital in the state of Florida to offer the U...
Heart Failure Patients, Clinicians Have Differing Perceptions of Risk Level
News | Heart Failure| September 06, 2017
September 6, 2017 — Physicians identified a majority of patients with advanced...
Israeli Hospital Completes First Implant of CORolla Heart Failure Device
News | Heart Failure| September 05, 2017
Rambam Hospital in Haifa, Israel, recently became the first to use the CORolla device from Israeli start-up company...
Advances in FFR, FFR-CT, was the most popular cardiology story in August 2017.

The most popular article in August was about advances in fractional flow reserve (FFR) technologies. The image shows Philips' new version of its iFR system that displays hemodynamic pressure drop points in an overlay on live angiographic images, matching up the iFR readings with corresponding lesions.

Feature | September 01, 2017 | Dave Fornell
September 1, 2017 — Here is the list of the most popular articles and videos on the Diagnostic and Interventional Car
Sponsored Content | Videos | Cardiovascular Ultrasound| August 30, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Overlay Init